US 11859185
Glucokinase (GCK) iRNA compositions and methods of use thereof
granted A61KA61K31/713A61K45/06
Quick answer
US patent 11859185 (Glucokinase (GCK) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/713, A61K45/06